1-5 of 5
Lynn O'Donnell, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Off-the-Shelf, Third-Party Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Sumithira Vasu, MDMBBS, Bhavana Bhatnagar, DO, James S. Blachly, MD, Nicole Szuminski, BS, Lynn O'Donnell, PhD, Dean Anthony Lee, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44.
https://doi.org/10.1182/blood-2020-139170
Published: 2020
Journal Articles

Safety and Efficacy of Virus-Specific Cytotoxic T-Lymphocytes Manufactured By the IFN-g Cytokine Capture System for the Treatment of Refractory Adenovirus, Cytomegalovirus, Epstein Barr Virus, and BK Virus Infections in Children, Adolescents and Young Adults after Allogeneic Hematopoietic Stem Cell Transplantation, Solid Organ Transplantation, or with Primary Immunodeficiency (IND# 17449)

Allyson M. Flower, MD, Rachel Friedmann, DO, Janet Ayello, MS, MT(ASCP), Olivia Rigot, PhD, Lauren Harrison, RN, MSN, Erin Morris, RN, BSN, Meghan Sturhahn, RN, MSN, Elana Maryamchik, MD, Yongping Wang, MD, Lynn O'Donnell, PhD, Rolla Abu-Arja, MD, Dean Anthony Lee, MD PhD, Julie-An Talano, MD, Bryon Johnson, PhD, Nancy Bunin, MD, Mitchell S Cairo, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–4.
https://doi.org/10.1182/blood-2020-140834
Published: 2020
Journal Articles

Cytomegalovirus Reactivation Does Not Increase Subsequent Risk for Acute Graft-Versus-Host Disease, Malignant Disease Relapse, or Infection Following Allogeneic Hematopoietic Cell Transplantation

Jeffery J Auletta, MD, Monica I Ardura, DO, Sumithira Vasu, MBBS, Ying Huang, MA, MS, Qiuhong Zhao, MS, Amy S. Ruppert, MAS, Abigail Shoben, PhD, Patrick Elder, MS, Anissa Bingman, MS, Rhonda Kitzler, MS, Gerard Lozanski, MD, Rolla Abu-Arja, MD, Hemalatha G. Rangarajan, MD, Rajinder Bajwa, MBBS, MD MRCP, Edwin M Horwitz, MD PhD, Lynn O'Donnell, PhD, Samantha Jaglowski, MD MPH, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, MD MPH, Craig C Hofmeister, Ashley E Rosko, MD, Don M Benson, MD PhD, Leslie A. Andritsos, MD, William Blum, MD, Steven M Devine, MD
Journal: Blood
Blood (2016) 128 (22): 3409.
https://doi.org/10.1182/blood.V128.22.3409.3409
Published: 2016
Journal Articles

Early Infection Attenuates Hematologic Malignant Disease Relapse Following Initial Allogeneic Hematopoietic Cell Transplantation

Jeffery J Auletta, MD, Monica I Ardura, DO, Sumithira Vasu, MBBS, Ying Huang, MA, MS, Qiuhong Zhao, MS, Amy S. Ruppert, MAS, Abigail Shoben, PhD, Patrick Elder, MS, Anissa Bingman, MS, Rhonda Kitzler, MS, Gerard Lozanski, MD, Rolla Abu-Arja, MD, Hemalatha G. Rangarajan, MD, Rajinder Bajwa, MBBS, MD MRCP, Edwin M Horwitz, MD PhD, Lynn O'Donnell, PhD, Samantha Jaglowski, MD MPH, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, MD MPH, Craig C Hofmeister, Ashley E Rosko, MD, Don M Benson, MD PhD, Leslie A. Andritsos, MD, William Blum, MD, Steven M Devine, MD
Journal: Blood
Blood (2016) 128 (22): 3410.
https://doi.org/10.1182/blood.V128.22.3410.3410
Published: 2016
Journal Articles

Determination of Optimal Target Antigen and Immune Modulatory Approaches to Improve and Standardize Epstein-Barr Virus-Specific Adoptive T Cell Therapy

Monica L Mitchell, John T. Patton, PhD, Lynn O'Donnell, PhD, Robert A. Baiocchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5817.
https://doi.org/10.1182/blood.V124.21.5817.5817
Published: 2014